Collplant Biotechnologies Ltd
CLGN0.800USD
+0.050+6.65%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
10.22MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Collplant Biotechnologies Ltd Unternehmen
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Collplant Biotechnologies Ltd Informationen
BörsenkürzelCLGN
Name des UnternehmensCollplant Biotechnologies Ltd
IPO-datumSep 01, 1993
CEORotem (Eran)
Anzahl der mitarbeiter57
WertpapierartOrdinary Share
GeschäftsjahresendeSep 01
Addresse4 Oppenheimer Street
StadtREHOVOT
BörseNASDAQ OMX - NASDAQ BASIC
LandIsrael
Postleitzahl7670104
Telefon972732325600
Websitehttps://www.collplant.com
BörsenkürzelCLGN
IPO-datumSep 01, 1993
CEORotem (Eran)
Führungskräfte von Collplant Biotechnologies Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
31.14K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
2.00K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gili Hart
Dr. Gili Hart
Independent Director
Independent Director
--
--
Dr. Elan Penn, Ph.D.
Dr. Elan Penn, Ph.D.
Independent Director
Independent Director
--
--
Dr. Roger J. Pomerantz, M.D.
Dr. Roger J. Pomerantz, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
31.14K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
2.00K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q2
FY2024
FY2024Q2
FY2023
FY2023Q2
FY2022
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Revenues from the sales of goods
179.00K
0.00%
Nach RegionUSD
Name
Umsatz
Anteil
Northern America
159.00K
88.83%
Europe
20.00K
11.17%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Revenues from the sales of goods
179.00K
0.00%
Aktionärsstatistik
Aktualisiert: Sat, Nov 15
Aktualisiert: Sat, Nov 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Sagy (Ami)
12.81%
Loewenbaum (George Walter II)
9.83%
St. Denis J. Villere & Company, LLC
4.75%
Pinnacle Associates Ltd.
4.36%
Loewenbaum (Lilian Shaw)
3.18%
Andere
65.06%
Aktionäre
Aktionäre
Anteil
Sagy (Ami)
12.81%
Loewenbaum (George Walter II)
9.83%
St. Denis J. Villere & Company, LLC
4.75%
Pinnacle Associates Ltd.
4.36%
Loewenbaum (Lilian Shaw)
3.18%
Andere
65.06%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
29.81%
Investment Advisor
7.56%
Investment Advisor/Hedge Fund
5.38%
Hedge Fund
1.74%
Research Firm
0.14%
Family Office
0.13%
Andere
55.25%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
34
1.82M
18.05%
--
2025Q3
36
1.82M
18.09%
-351.44K
2025Q2
36
2.17M
13.51%
+569.42K
2025Q1
36
2.09M
19.82%
-180.41K
2024Q4
38
2.54M
24.36%
-57.22K
2024Q3
40
2.59M
23.16%
+143.75K
2024Q2
40
2.45M
24.33%
+72.69K
2024Q1
40
2.38M
24.25%
-401.71K
2023Q4
45
2.39M
26.23%
-101.34K
2023Q3
46
2.49M
28.02%
-60.71K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Sagy (Ami)
1.64M
12.81%
-306.10K
-15.75%
Nov 19, 2025
Loewenbaum (George Walter II)
1.26M
9.83%
--
--
Nov 06, 2025
St. Denis J. Villere & Company, LLC
588.72K
4.61%
+41.85K
+7.65%
Sep 30, 2025
Pinnacle Associates Ltd.
507.19K
3.97%
--
--
Sep 30, 2025
Loewenbaum (Lilian Shaw)
406.29K
3.18%
-245.19K
-37.64%
Nov 06, 2025
Evans (Hugh M)
377.43K
2.95%
-1.00
-0.00%
Mar 15, 2025
Roumell Asset Management, L.L.C.
276.43K
2.16%
-38.86K
-12.32%
Jun 30, 2024
AMH Equity, Ltd.
200.00K
1.57%
+39.15K
+24.34%
Sep 30, 2025
Brown Advisory
118.73K
0.93%
+7.55K
+6.79%
Sep 30, 2025
Benjamin F. Edwards & Company, Inc.
39.76K
0.31%
-10.69K
-21.19%
Jun 30, 2024
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
